Mediar Therapeutics Series B co-led by ICG Life Sciences
Primary Investment · 07/01/2026
Transaction overview
- Transaction type
- Primary Investment
- Asset class
- Venture Capital
- Announced
- 07/01/2026
Sign in for recorded transaction details and disclosed amounts. The connected firm profile provides context on its investment strategies, funds and relationships.
DataBane research access
See the connections behind the profile
Create a free account to unlock five distinct firm profiles per day. Explore recorded financial history, allocations, funds, deals, people and relationships where available.
Five profiles daily · resets at your local midnight · no credit card required